Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA
· Real-Time Price · USD
1.36
-0.01 (-0.73%)
At close: Oct 09, 2025, 3:49 PM
Ernexa Therapeutics Revenue
Ernexa Therapeutics reported an annual revenue of $582K, reflecting a 755.88% growth. For the quarter ending June 30, 2025, Ernexa Therapeutics generated $0 in revenue.
Revenue (ttm)
582K
Revenue Growth
755.88%
Price / Sales Ratio
215.18
Revenue / Employee
97K
Employees
6
Market Cap
10.42M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 582K | +755.88% |
| Dec 31, 2023 | 68K | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | -100.00% |
| Dec 31, 2019 | 19.81M | -15.12% |
| Dec 31, 2018 | 23.34M | +9.69% |
| Dec 31, 2017 | 21.27M | -4.65% |
| Dec 31, 2016 | 22.31M | -9.00% |
| Dec 31, 2015 | 24.52M | n/a |